| human | Q5 |
| P6178 | Dimensions author ID | 0665362121.44 |
| P227 | GND ID | 115581820 |
| P496 | ORCID iD | 0000-0001-9737-337X |
| P1153 | Scopus author ID | 7201702768 |
| P214 | VIAF ID | 20412948 |
| P10832 | WorldCat Entities ID | E39PBJwxPMbRT7gXjYdCtp7T73 |
| P734 | family name | Weber | Q1409226 |
| Weber | Q1409226 | ||
| Weber | Q1409226 | ||
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | male | Q6581097 |
| Q103806023 | A DNA-based vaccine protects against Crimean-Congo haemorrhagic fever virus disease in a Cynomolgus macaque model |
| Q45753472 | A classical bipartite nuclear localization signal on Thogoto and influenza A virus nucleoproteins |
| Q91913317 | A comprehensive annotation and differential expression analysis of short and long non-coding RNAs in 16 bat genomes |
| Q36368645 | A target on the move: innate and adaptive immune escape strategies of hepatitis C virus |
| Q35587097 | A virus-like particle system identifies the endonuclease domain of Crimean-Congo hemorrhagic fever virus |
| Q34975543 | Activation of PKR by Bunyamwera virus is independent of the viral interferon antagonist NSs. |
| Q24337029 | Activation of innate defense against a paramyxovirus is mediated by RIG-I and TLR7 and TLR8 in a cell-type-specific manner |
| Q34895197 | Antigenic drift, antigenic shift and interferon antagonists: how bunyaviruses counteract the immune system |
| Q35000433 | Bunyamwera bunyavirus nonstructural protein NSs counteracts the induction of alpha/beta interferon. |
| Q39776458 | Bunyamwera virus nonstructural protein NSs counteracts interferon regulatory factor 3-mediated induction of early cell death |
| Q27664646 | Bunyaviridae RNA Polymerases (L-Protein) Have an N-Terminal, Influenza-Like Endonuclease Domain, Essential for Viral Cap-Dependent Transcription |
| Q38613824 | Bunyaviruses and the type I interferon system |
| Q113269597 | Comparison of Crimean-Congo Hemorrhagic Fever Virus and Aigai Virus in Life Cycle Modeling Systems Reveals a Difference in L Protein Activity |
| Q33892350 | Completion of hepatitis C virus replication cycle in heterokaryons excludes dominant restrictions in human non-liver and mouse liver cell lines. |
| Q47129052 | Conserved RNA structures in the intergenic regions of ambisense viruses |
| Q57017473 | Conserved vRNA end sequences of Thogoto-orthomyxovirus suggest a new panhandle structure |
| Q57017389 | Control of coronavirus infection through plasmacytoid dendritic-cell-derived type I interferon |
| Q33294059 | Coronavirus non-structural protein 1 is a major pathogenicity factor: implications for the rational design of coronavirus vaccines |
| Q39972576 | Crimean-Congo hemorrhagic fever virus delays activation of the innate immune response |
| Q33558501 | Differential downregulation of ACE2 by the spike proteins of severe acute respiratory syndrome coronavirus and human coronavirus NL63. |
| Q42425012 | Double-stranded RNA is produced by positive-strand RNA viruses and DNA viruses but not in detectable amounts by negative-strand RNA viruses |
| Q33911860 | Efficient cDNA-based rescue of La Crosse bunyaviruses expressing or lacking the nonstructural protein NSs. |
| Q39893246 | Efficient production of Rift Valley fever virus-like particles: The antiviral protein MxA can inhibit primary transcription of bunyaviruses |
| Q40397884 | Electron cryo-microscopy and single-particle averaging of Rift Valley fever virus: evidence for GN-GC glycoprotein heterodimers |
| Q92667969 | Elongin C Contributes to RNA Polymerase II Degradation by the Interferon Antagonist NSs of La Crosse Orthobunyavirus |
| Q38793701 | Evolution and Antiviral Specificities of Interferon-Induced Mx Proteins of Bats against Ebola, Influenza, and Other RNA Viruses. |
| Q39655590 | Extracellular 2'-5' oligoadenylate synthetase stimulates RNase L-independent antiviral activity: a novel mechanism of virus-induced innate immunity |
| Q91763407 | Ferreting out viral pathogenesis |
| Q40655819 | Functional L polymerase of La Crosse virus allows in vivo reconstitution of recombinant nucleocapsids |
| Q34434866 | Global suppression of the host antiviral response by Ebola- and Marburgviruses: increased antagonism of the type I interferon response is associated with enhanced virulence |
| Q40937979 | High-efficiency detection of severe acute respiratory syndrome virus genetic material |
| Q42334236 | Homage to Richard M. Elliott |
| Q39187107 | Human cell tropism and innate immune system interactions of human respiratory coronavirus EMC compared to those of severe acute respiratory syndrome coronavirus |
| Q24305895 | IFIT1 is an antiviral protein that recognizes 5'-triphosphate RNA |
| Q57017320 | IFIT2 Is an Effector Protein of Type I IFN-Mediated Amplification of Lipopolysaccharide (LPS)-Induced TNF- Secretion and LPS-Induced Endotoxin Shock |
| Q99546647 | ISG15 overexpression compensates the defect of Crimean-Congo hemorrhagic fever virus polymerase bearing a protease-inactive ovarian tumor domain |
| Q116170955 | Identification and characterization of short leader and trailer RNAs synthesized by the Ebola virus RNA polymerase |
| Q33915111 | Incoming RNA virus nucleocapsids containing a 5'-triphosphorylated genome activate RIG-I and antiviral signaling |
| Q35801885 | Induction of DNA damage signaling upon Rift Valley fever virus infection results in cell cycle arrest and increased viral replication |
| Q40327030 | Induction of interferon synthesis by the PKR-inhibitory VA RNAs of adenoviruses |
| Q35177555 | Influenza virus adaptation PB2-627K modulates nucleocapsid inhibition by the pathogen sensor RIG-I. |
| Q33781480 | Inhibition of Beta interferon induction by severe acute respiratory syndrome coronavirus suggests a two-step model for activation of interferon regulatory factor 3. |
| Q24302351 | Inhibition of Dugbe nairovirus replication by human MxA protein |
| Q40554311 | Inhibition of RNA polymerase II phosphorylation by a viral interferon antagonist |
| Q96685273 | Inhibition of SARS-CoV-2 by type I and type III interferons |
| Q43220708 | Interaction of severe acute respiratory syndrome-associated coronavirus with dendritic cells |
| Q37332576 | Interferon and cytokine responses to Crimean Congo hemorrhagic fever virus; an emerging and neglected viral zonoosis |
| Q37102729 | Interferon and cytokine responses to SARS-coronavirus infection |
| Q34536954 | Interferon antagonist NSs of La Crosse virus triggers a DNA damage response-like degradation of transcribing RNA polymerase II. |
| Q34993512 | Interferon priming enables cells to partially overturn the SARS coronavirus-induced block in innate immune activation |
| Q34660504 | Interferon, Mx, and viral countermeasures |
| Q27480353 | La Crosse Bunyavirus Nonstructural Protein NSs Serves To Suppress the Type I Interferon System of Mammalian Hosts |
| Q39692178 | La Crosse virus (LACV) Gc fusion peptide mutants have impaired growth and fusion phenotypes, but remain neurotoxic |
| Q37254398 | Middle East respiratory syndrome coronavirus accessory protein 4a is a type I interferon antagonist |
| Q57017486 | Molecular Biology of Rift Valley Fever Virus~!2009-11-04~!2009-11-25~!2010-04-22~! |
| Q59352330 | NSs Protein of Sandfly Fever Sicilian Phlebovirus Counteracts Interferon (IFN) Induction by Masking the DNA-Binding Domain of IFN Regulatory Factor 3 |
| Q38774860 | NSs Virulence Factor of Rift Valley Fever Virus Engages the F-Box Proteins FBXW11 and β-TRCP1 To Degrade the Antiviral Protein Kinase PKR |
| Q39960501 | NSs protein of Rift Valley fever virus blocks interferon production by inhibiting host gene transcription |
| Q39195523 | NSs protein of rift valley fever virus induces the specific degradation of the double-stranded RNA-dependent protein kinase |
| Q34595308 | Neurons produce type I interferon during viral encephalitis |
| Q27473101 | Novel gene product of Thogoto virus segment 6 codes for an interferon antagonist |
| Q91034554 | Nuclear pore protein Nup98 is involved in replication of Rift Valley fever virus and nuclear import of virulence factor NSs |
| Q120690548 | Omicron variant of SARS-CoV-2 exhibits an increased resilience to the antiviral type I interferon response |
| Q26747457 | Phleboviruses and the Type I Interferon Response |
| Q27485881 | Processing of Genome 5′ Termini as a Strategy of Negative-Strand RNA Viruses to Avoid RIG-I-Dependent Interferon Induction |
| Q38217394 | RIG-I-like receptors and negative-strand RNA viruses: RLRly bird catches some worms |
| Q27861007 | RIG-I-mediated antiviral responses to single-stranded RNA bearing 5'-phosphates |
| Q104069288 | Recombinant Rift Valley fever viruses encoding bluetongue virus (BTV) antigens: Immunity and efficacy studies upon a BTV-4 challenge |
| Q30413201 | Regulatory, biosafety and safety challenges for novel cells as substrates for human vaccines |
| Q34193444 | Reverse genetics of SARS-related coronavirus using vaccinia virus-based recombination |
| Q40182361 | SUMO modification of TBK1 at the adaptor-binding C-terminal coiled-coil domain contributes to its antiviral activity |
| Q47570129 | Second International Conference on Crimean-Congo Hemorrhagic Fever. |
| Q38220302 | Segmented negative-strand RNA viruses and RIG-I: divide (your genome) and rule |
| Q37099661 | Severe acute respiratory syndrome coronavirus triggers apoptosis via protein kinase R but is resistant to its antiviral activity |
| Q33405724 | Severe fever with thrombocytopenia virus glycoproteins are targeted by neutralizing antibodies and can use DC-SIGN as a receptor for pH-dependent entry into human and animal cell lines |
| Q39734555 | Species-independent bioassay for sensitive quantification of antiviral type I interferons |
| Q30244017 | Standing on three legs: antiviral activities of RIG-I against influenza viruses |
| Q27677399 | Structural basis for encapsidation of genomic RNA by La Crosse Orthobunyavirus nucleoprotein |
| Q27682730 | Structural insights into RNA encapsidation and helical assembly of the Toscana virus nucleoprotein |
| Q90477359 | Structure and function of the Toscana virus cap-snatching endonuclease |
| Q27672351 | Structure of Crimean-Congo Hemorrhagic Fever Virus Nucleoprotein: Superhelical Homo-Oligomers and the Role of Caspase-3 Cleavage |
| Q39946457 | T7 RNA polymerase-dependent and -independent systems for cDNA-based rescue of Rift Valley fever virus |
| Q113251472 | Targeted Mutations in the Fusion Peptide Region of La Crosse Virus Attenuate Neuroinvasion and Confer Protection against Encephalitis |
| Q39551895 | The ADP-ribose-1''-monophosphatase domains of severe acute respiratory syndrome coronavirus and human coronavirus 229E mediate resistance to antiviral interferon responses |
| Q40823920 | The Bunyamwera virus nonstructural protein NSs inhibits viral RNA synthesis in a minireplicon system |
| Q59349848 | The DEVD motif of Crimean-Congo hemorrhagic fever virus nucleoprotein is essential for viral replication in tick cells |
| Q112699033 | The International Virus Bioinformatics Meeting 2022 |
| Q97527665 | The SARS-CoV-2 N protein is a good component in a vaccine |
| Q34064211 | The SARS-coronavirus-host interactome: identification of cyclophilins as target for pan-coronavirus inhibitors |
| Q103812983 | The Short- and Long-Range RNA-RNA Interactome of SARS-CoV-2 |
| Q47624938 | The antiviral effect of interferon-beta against SARS-coronavirus is not mediated by MxA protein |
| Q41096425 | The fourth genus in the Orthomyxoviridae: sequence analyses of two Thogoto virus polymerase proteins and comparison with influenza viruses |
| Q39943779 | The interferon antagonist ML protein of thogoto virus targets general transcription factor IIB. |
| Q36346824 | The interferon response circuit: induction and suppression by pathogenic viruses |
| Q99589486 | The interplays between Crimean-Congo hemorrhagic fever virus (CCHFV) M segment-encoded accessory proteins and structural proteins promote virus assembly and infectivity |
| Q56877432 | The intracellular sites of early replication and budding of SARS-coronavirus |
| Q90597022 | The secRNome of Listeria monocytogenes Harbors Small Noncoding RNAs That Are Potent Inducers of Beta Interferon |
| Q57017358 | Thogoto virus ML protein is a potent inhibitor of the interferon regulatory factor-7 transcription factor |
| Q44180219 | Thogoto virus ML protein suppresses IRF3 function |
| Q34055431 | Tick-borne encephalitis virus delays interferon induction and hides its double-stranded RNA in intracellular membrane vesicles |
| Q38903946 | To Conquer the Host, Influenza Virus Is Packing It In: Interferon-Antagonistic Strategies beyond NS1. |
| Q39652674 | Toscana virus induces interferon although its NSs protein reveals antagonistic activity |
| Q40092449 | Tula and Puumala hantavirus NSs ORFs are functional and the products inhibit activation of the interferon-beta promoter |
| Q40399200 | Vaccination with virus-like particles protects mice from lethal infection of Rift Valley Fever Virus |
| Q29147519 | Viperin is an iron-sulfur protein that inhibits genome synthesis of tick-borne encephalitis virus via radical SAM domain activity |
| Q57017454 | Viral Evasion of the Interferon System: Old Viruses, New Tricks |
| Q57017446 | Viral anti-interferon strategies: mechanisms and clinical impact |
| Q24293704 | Viral immune modulators perturb the human molecular network by common and unique strategies |
| Q36750723 | Viral suppression of the interferon system |
| Q38326807 | Virulence factor NSs of rift valley fever virus recruits the F-box protein FBXO3 to degrade subunit p62 of general transcription factor TFIIH |
| Q92986055 | Virus- and Interferon Alpha-Induced Transcriptomes of Cells from the Microbat Myotis daubentonii |
| Q39653963 | Virus-like particles expressing the nucleocapsid gene as an efficient vaccine against Rift Valley fever virus |
| Q97519293 | eIF2B as a Target for Viral Evasion of PKR-Mediated Translation Inhibition |
| Q112712143 | eIF2B-capturing viral protein NSs suppresses the integrated stress response |
| Q30400470 | pH Optimum of Hemagglutinin-Mediated Membrane Fusion Determines Sensitivity of Influenza A Viruses to the Interferon-Induced Antiviral State and IFITMs |
Search more.